Inflammation and insulin resistance partially mediate the relationship between age at menopause and depression in postmenopausal women
This study looked at more than 7,000 women over 60 in the US (NHANES 2005–2020) to understand how the age at menopause relates to depression in later life, and whether inflammation and insulin resistance help explain that link.
What the researchers did
- Included women aged 60+ who reported their age at menopause, use of hormone therapy, health conditions and lifestyle, and who completed the PHQ‑9 depression questionnaire (depression defined as PHQ‑9 ≥10).
- Measured blood C‑reactive protein (CRP) as a marker of chronic inflammation and calculated HOMA‑IR as a marker of insulin resistance.
- Used survey‑weighted logistic regression, Bayesian models, and causal mediation analysis to see how these factors related.
Key findings
- Earlier menopause was linked with more depression in women over 60: the younger the age at menopause, the higher the odds of clinically relevant depression.
- Self‑reported hormone therapy was not significantly associated with depression overall, while higher education was consistently protective.
- Inflammation (CRP) and insulin resistance (HOMA‑IR) partially “mediated” the relationship between age at menopause and depression, meaning they accounted for part of the statistical link between earlier menopause and later‑life depression.
- The mediating effects were statistically detectable but small in size, suggesting that inflammation and insulin resistance are real biological pathways in this relationship, but not the whole story.
- Obesity (BMI ≥30) was associated with roughly twice the odds of depression compared with normal weight, reinforcing the role of metabolic load.
Source: Menopause
- The study supports the idea that earlier menopause marks a longer exposure to a pro‑inflammatory, insulin‑resistant milieu in later life, which in turn is tied to higher depression risk.
- It shows that metabolic inflammation and impaired insulin signalling are key pieces of the puzzle, rather than depression being explained purely by “less oestrogen” or by hormone therapy use.
- This aligns with a systems view of postmenopausal mood: the timing of menopause influences how long the brain and body live in a state of chronic low‑grade inflammation and metabolic stress, and that internal environment is what shapes vulnerability to depression in older women.
-
This study looked at more than 7,000 women over 60 in the US (NHANES 2005–2020) to understand how the age at menopause relates to depression in later life,…
-
3,000 women were followed for 10 years to ask a simple question: does the menopausal transition itself increase the risk of significant anxiety symptoms? What was…
-
This long-term study followed 233 women from before menopause to after their final period to see how different types of anxiety relate to hot flushes.…
-
This study followed 122 late peri‑ and postmenopausal women (average age 59) to see how their sleep relates to early brain changes that raise the…
-
An analysis of whether “moderate” alcohol intake (even within current guidelines) is linked to higher iron in the brain and, in turn, to worse cognitive…
-
Age‑related cognitive decline, including Alzheimer’s disease, can be understood as a myelin problem rather than only a “plaques and tangles” problem. Myelin is the fatty insulation around…
-
In a small number of animal species, females cease reproducing long before the end of their natural lifespan. A prolonged post‑reproductive life stage is exceptionally…
-
Copper has two key properties that are being exploited in consumer and medical device products in the last decade. On the one hand, copper has…
-
While osteoporosis and psychological stress occur via differing mechanisms, there are several potential molecular links that exist between a pathological response to stress and the…
-
Excess glucocorticoids are well recognised as a cause of osteoporosis; they inhibit osteoblast function and increase osteoblast and osteocyte apoptosis resulting in thinning of the…
-
Osteoporosis, a consequence of menopause in the biological cycle of women, emerges with the conclusion of reproductive capabi lities.Hormonal changes during this phase contribute to…
-
The purpose of this study was to determine the longitudinal association between menopausal vasomotor symptoms (VMS) and urinary N-telopeptide level (NTX) according to menopausal stage. We…
-
Objective: To determine whether women with vasomotor symptoms (VMS) have lower bone mineral density (BMD) than women without VMS. Design We analyzed data from baseline…
-
Background: Osteocalcin, has high affinity for calcium. In osteoporotic women, deficiency of calcium may lead to lowering of the formation of hydroxyapatite crystals. Thus, in the…
-
A severe impairment of cognitive function characterizes dementia. Mild cognitive impairment represents a transition between normal cognition and dementia. The frequency of cognitive changes is…